| Mar. |
22,2011 |
|
Updated "Corporate Profile." |
 |
|
|
| Feb. |
04,2011 |
|
Updated "Research
and Development Pipeline." |
|
|
|
| Nov. |
10,2010 |
|
Updated "Research
and Development Pipeline." |
|
|
|
| Oct. |
1,2010 |
|
Updated "Research
and Development Pipeline." |
|
|
|
| Sep. |
29,2010 |
 |
PRESS
RELEASE
(Announcement of the NDA submission of Z-338 /YM443 for functional dyspepsia in Japan)(PDF64.5KB) |
|
|
|
| Jun. |
28,2010 |
|
PRESS
RELEASE
(Announcement of the results from Phase III, double blind, placebo-controlled study of Z-338 for functional dyspepsia conducted in Japan)(PDF48.3KB) |
|
|
|
| May. |
17,2010 |
|
Updated "Research
and Development Pipeline." |
|
|
|
| Apr. |
8,2010 |
|
PRESS
RELEASE
(Announcement of Conclusion of Comprehensive and Exclusive Contract for Domestic
Development and Sales with US Company HemCon Medical Technologies Inc.)(PDF156KB) |
|
|
|
| Mar. |
1,2010 |
|
Updated "Research
and Development Pipeline." |
|
|
|
| Feb. |
9,2010 |
|
Updated "Research
and Development Pipeline." |
|
|
|
| Jan. |
6,2010 |
|
Updated "Research
and Development Pipeline." |
|
|
|
| Dec. |
11,2009 |
|
PRESS RELEASE
(Launch of "Asacol® Tablets 400mg", Agent for Ulcerative Colitis)(PDF96KB) |
|
|
|
| Jun. |
15,2009 |
|
PRESS RELEASE
(Announcement of presentation of the results from clinical pharmacological study of Z-338 (acotiamide hydrochloride hydrate) at Digestive Disease Week 2009)(PDF/57KB) |
|
|
|
| May. |
21,2009 |
|
PRESS RELEASE
(Approval of "Promac® granules 15%", Zinc Containing Anti-gastric Ulcer Agent, in Korea)(PDF/178KB) |
|
|
|
| May. |
19,2009 |
|
Updated "Research
and Development Pipeline." |
|
|
|
| Mar. |
3,2009 |
|
PRESS RELEASE
(Announcement of the results from Phase II study of Z-338 for functional dyspepsia conducted in Europe) (PDF/56KB) |
|
|
|
| Oct. |
8,2008 |
|
Updated "Research
and Development Pipeline." |
|
|
|
| Aug. |
7,2008 |
|
Updated "Research
and Development Pipeline." |
|
|
|
| Jun. |
11,2008 |
|
Updated "Research
and Development Pipeline." |
|
|
|
| Jun. |
6,2008 |
|
Financial Summary
(For the fiscal year ended March 31, 2008) (PDF/109KB)
|
|
|
|
| May. |
13,2008 |
|
Updated "Research
and Development Pipeline." |
|
|
|
| Mar. |
25,2008 |
|
Updated "Research
and Development Pipeline." |
|
|
|
| Mar. |
10,2008 |
|
PRESS RELEASE
(Conclusion of Co-Development and Co-Marketing Agreement on Z-338
for Functional Dyspepsia in Japan with Astellas Pharma Inc.) (PDF/36KB) |
|
|
|
| Jan. |
29,2008 |
|
Updated "Major New Drug Developments." |
|
|
|
| Dec. |
14,2007 |
|
Updated "Major New Drug Developments." |
|
|
|
| Nov. |
01,2007 |
|
Updated "Major New Drug Developments." |
|
|
|
| Nov. |
01,2007 |
|
Updated "Business Field" & "Main Products" |
|
|
|
| Oct. |
01,2007 |
|
Updated "Major New Drug Developments." |
|
|
|
| Aug. |
28,2007 |
|
PRESS RELEASE
(ZERIA LICENSES TM-411 FOR HEPATOCELLULAR CARCINOMA (HCC)) (PDF/118KB)
|
|
|
|
| Aug. |
01,2007 |
|
Updated "Major New Drug Developments." |
|
|
|
| Jun. |
12,2007 |
|
Financial Summary
(For the fiscal year ended March 31, 2007) (PDF/96KB)
|
|
|
|
| Jun. |
08,2007 |
|
PRESS RELEASE
(LAUNCH OF ORAL FORMULATION COLON CLEANSING VISICLEAR® TABLETS) (PDF/116KB)
|
|
|
|
| May. |
17,2007 |
|
Updated "Major New Drug Developments." |
|
|
|
| Feb. |
08,2007 |
|
Updated "Major New Drug Developments." |
|
|
|
| Feb. |
06,2007 |
|
PRESS RELEASE
(Conclusion of Co-development and Co-marketing Agreement of ASACOL® for Inflammatory Bowel Disease, with Kyowa Hakko Kogyo Co.,Ltd.) (PDF/137KB) |
|
|
|
| Dec. |
01,2006 |
|
Contents are up dated. |
|
|
|
| Aug. |
11,2006 |
|
Launched Chondroitin Information. |
|
|
|
| May. |
29,2006 |
|
Consolidated Financial Summary
(For the fiscal year ended March 31,2006) (PDF/141KB) |
|
|
|
| May. |
29,2006 |
|
Non-consolidated Financial Summary
(For the fiscal year ended March 31,2006) (PDF/151KB) |
|
|
|
| May. |
19,2006 |
|
Updated "Major New Drug Developments." |
|
|
|
| Mar. |
16,2006 |
|
PRESS RELEASE
(Zeria and SK Chemicals have entered into a License Agreement)(PDF/153KB) |
|
|
|
| Nov. |
30,2005 |
|
Consolidated Financial Summary
(For the interim period of fiscal year ending March 31,2006) (PDF/72KB) |
|
|
|
| Nov. |
30,2005 |
|
Non-consolidated Financial Summary
(For the interim period of fiscal year ending March 31,2006) (PDF/71KB) |
|
|
|
| Nov. |
16,2005 |
|
Updated "Major New Drug Developments." |
|
|
|
| Nov. |
01,2005 |
|
Relaunched Zeria's English website. |
|
|
|
| Jul. |
01,2002 |
|
ZERIA AND YAMANOUCHI SIGN LETTER OF INTENT FOR DEVELOPMENT AND MARKETING OF THE GASTROPROKINETIC Z-338 (PDF/327KB) |